Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
5.59
+0.29 (5.47%)
At close: Sep 22, 2026, 4:00 PM EDT
5.59
0.00 (0.00%)
After-hours: Sep 22, 2026, 4:53 PM EDT
Embecta Market Cap
Embecta has a market cap or net worth of $316.73 million as of September 22, 2026. Its market cap has decreased by -62.23% in one year.
Market Cap
316.73M
Enterprise Value
1.60B
1-Year Change
-62.23%
Ranking
Category
Stock Price
$5.59
ChartMarket Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $316.73M, a decrease of -88.16%. That is a compound annual growth rate of -37.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 316.73M | -54.97% |
| Dec 31, 2025 | 703.44M | -41.40% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
| Mar 22, 2022 | 2.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| STAAR Surgical Company | 1.04B |
| AngioDynamics | 638.17M |
| Sanara MedTech | 322.22M |
| OraSure Technologies | 245.53M |
| Utah Medical Products | 235.48M |
| Pro-Dex | 232.40M |
| Anbio Biotechnology | 230.43M |
| Jin Medical International | 156.08M |